FDA MAP
  • Home
  • Training
    • WORKSHOPS
    • WEBINARS
    • CUSTOM TRAINING
  • SERVICES
    • REGULATORY SERVICES
    • FDA AUDITING
    • QUALITY ASSURANCE
    • CLINICAL TRIAL SERVICES
  • News Releases
  • About Us
Newsletter - July 14, 2016

FDA Clarifies: You Cannot Compound Approved Drugs 

Last year, during the drug pricing debate triggered by Turing Pharma’s Martin Shkreli, a San Diego compounding pharmacy Imprimis Pharmaceuticals announced that it would offer a cheap compounded version of the expensive FDA-approved drug. At that time, we criticized Imprimis based on our belief that such a practice will jeopardize all approved drugs. This week FDA confirmed our concern and took measures to stop such activities by compounding pharmacies. Read More..

What Sunshine Act? Are Payments to Doctors by Companies Undeterred?  
​
A review of the payments to physicians posted on the CMS Open Payment website indicates that there has been no decrease in the payments to physicians by companies. In 2015, drug companies paid $7.52 billion just like the $7.49 billion paid last year to more than 600,000 physicians of almost all kinds of specializations. The list of top 10 companies paying physicians stayed mostly the same. Read More..


Our Services

  • Workshops
  • Webinars
  • On-Demand Webinars
  • Custom training
  • Training Subscriptions
  • Corporate Registration
  • Certification Program
  • Smart Recruitment
  • Corporate Registration - Online Workshop​



Company

  • About Us​
  • Testimonials
  • Free Resources
  • Newsletter
  • Videos (Free Tutorials)

Support

  • Contact Us
  • Terms of Service
  • Privacy Policy
  • News Archive
Consultation Service
FDA Training Company
Copyright © 2021 FDAMap.com
Use of this Web site constitutes acceptance of the FDAMap Terms of Use and Privacy Policy.